Simon Zehava sold $456K of NVMI

Simon Zehava sold 820 shares of NOVA LTD. (NVMI) at an average of $556.46 ($536.52–$581.20, $0.46M total) across 2 trades over 2026-06-22 to 2026-06-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Simon Zehava
Published Jun 24, 2026, 6:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 6:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NVMI
Neutral
medium confidence
Mentioned
$NVMI
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVMINeutralLow
01

Why it matters

The disclosed sale amount ($456.3K) and share prices ($536.52–$581.20) provide transparency on insider behavior, but the filing does not include any new company performance or strategic developments.

02

Market read

Use as a sentiment/positioning input rather than a standalone fundamental catalyst.

03

What to watch

Traders may over-weight single insider sales; without concurrent news (earnings, guidance, contracts), the signal is typically weak.

Relevance 3/10Novelty 5/10Timing: today’s SEC Form 4 filing (filed 2026-06-24) discloses the 6/22–6/23 sale details

Background

The article is an SEC Form 4 insider transaction disclosure for NOVA Ltd. (NVMI) by director Simon Zehava.

Company-level read

Ticker impact

$NVMINeutralMedium confidence
Context

NOVA Ltd. (NVMI) disclosed via SEC Form 4 that director Simon Zehava sold $456.3K of NVMI shares under a 10b5-1 plan on 6/22–6/23.

Expected impact

Likely limited near-term impact; any effect should be small and transient unless followed by additional disclosures.

Evidence & confidence

The filing is a routine Form 4 transaction with a pre-arranged 10b5-1 plan and no accompanying operational or financial guidance changes in the text.

Market effects

No sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish information.

Key entities

  • NOVA Ltd.

    Company whose shares were sold; subject of the Form 4 insider transaction.

  • Simon Zehava

    Director who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVMIMed

Nova Q3 Earnings Call Highlights

Nova (NVMI) reported strong Q3 results, with record advanced packaging sales and significant demand for its WMC platform. Logic and foundry accounted for 61% of product revenue. The company forecasted Q4 revenue of $305M-$315M and expects GAAP EPS of $2.78-$2.94. Nova ended Q3 with $1.8B in cash and repurchased $38.5M of shares. It plans to discuss future strategy at an investor day in March 2027.

$NVMIMed

Nova Ltd (NVMI) Q3 2026 Earnings Call Highlights: Record Revenue, $1 Billion Milestone

Nova Ltd (NVMI) reported record Q3 2026 revenue, reaching $1 billion. The company faces supply chain constraints and expects new competition in materials metrology. Gross margin is guided to remain flat at 59%. Operating expenses are expected to increase in Q4 2026 due to higher R&D spending. CEO Gabriel Waisman highlighted growth opportunities in memory and gate-all-around metrology, with strong demand for the Metrion tool despite longer lead times.

$NVMIHighAI 8/10

Nova (NVMI) Q3 2026 Earnings Call Transcript

Nova (NVMI) reported Q3 2026 revenue of $287.8M, up 13% QoQ and 28% YoY, driven by strong demand in memory, advanced packaging, and logic segments. The company expects to exceed $1B in annual revenue, a year ahead of plan. Q4 guidance projects revenue between $305M-$315M and EPS between $2.78-$2.94 (GAAP) and $3.03-$3.18 (non-GAAP).